title: Distinct retinal deficits in a zebrafish pyruvate dehydrogenase-deficient mutant.
abstract: Mutations in ubiquitously expressed metabolic genes often lead to CNS-specific effects, presumably because of the high metabolic demands of neurons. However, mutations in omnipresent metabolic pathways can conceivably also result in cell type-specific effects because of cell-specific requirements for intermediate products. One such example is the zebrafish noir mutant, which we found to be mutated in the pdhb gene, coding for the E1 beta subunit of the pyruvate dehydrogenase complex. This vision mutant is described as blind and was isolated because of its vision defect-related darker appearance. A detailed morphological, behavioral, and physiological analysis of the phenotype revealed an unexpected specific effect on the retina. Surprisingly, the cholinergic amacrine cells of the inner retina are affected earlier than the photoreceptors. This might be attributable to the inability of these cells to maintain production of their neurotransmitter acetylcholine. This is reflected in an earlier loss of motion vision, followed only later by a general loss of light perception. Since both characteristics of the phenotype are attributable to a loss of acetyl-CoA production by pyruvate dehydrogenase, we used a ketogenic diet to bypass this metabolic block and could indeed partially rescue vision and prolong survival of the larvae. The noir mutant provides a case for a systemic disease with ocular manifestation with a surprising specific effect on the retina given the ubiquitous requirement for the mutated gene.
authors.affiliation: University of Zurich, Institute of Molecular Life Sciences, Neuroscience Center Zurich and Center for Integrative Human Physiology, Zurich, Switzerland.
authors.forename: Colette M
authors.initials: CM
authors.lastname: Maurer
authors.forename: Helia B
authors.initials: HB
authors.lastname: Schönthaler
authors.forename: Kaspar P
authors.initials: KP
authors.lastname: Mueller
authors.forename: Stephan C F
authors.initials: SC
authors.lastname: Neuhauss
mesh_terms: D000613:Aminobutyrates / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D030801:Animals, Genetically Modified; D001224:Aspartic Acid / Q000494:pharmacology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004252:DNA Mutational Analysis; D055423:Diet, Ketogenic / Q000379:methods; D004195:Disease Models, Animal; D004596:Electroretinography / Q000379:methods; D004625:Embryo, Nonmammalian; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D007814:Larva; D009068:Movement / Q000502:physiology; D009154:Mutation / Q000235:genetics*; D017120:Nystagmus, Optokinetic / Q000235:genetics / Q000502:physiology; D010775:Photic Stimulation / Q000379:methods; D011767:Pyruvate Decarboxylase / Q000172:deficiency*; D012160:Retina / Q000166:cytology / Q000196:embryology / Q000254:growth & development / Q000473:pathology; D012164:Retinal Diseases / Q000175:diagnosis* / Q000178:diet therapy / Q000235:genetics*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000235:genetics
chemical_list: D000613:Aminobutyrates; D018690:Excitatory Amino Acid Agonists; D029961:Zebrafish Proteins; C120673:benzyloxyaspartate; D001224:Aspartic Acid; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D011767:Pyruvate Decarboxylase; C012729:2-amino-4-phosphonobutyric acid
references.citation: Neuron. 2007 Jul 19;55(2):179-86
references.pmid: 17640521
references.citation: J Vis Exp. 2008 Oct 03;(20):
references.pmid: 19078942
references.citation: J Neurocytol. 2001 Jul;30(7):551-92
references.pmid: 12118162
references.citation: Dev Biol. 2002 Aug 15;248(2):307-18
references.pmid: 12167406
references.citation: Brain Res. 2005 Oct 5;1058(1-2):17-29
references.pmid: 16150425
references.citation: Brain Res Bull. 2005 Sep 15;66(4-6):421-5
references.pmid: 16144624
references.citation: Exp Eye Res. 2007 Aug;85(2):175-84
references.pmid: 17618621
references.citation: Invest Ophthalmol Vis Sci. 1976 Sep;15(9):700-25
references.pmid: 986765
references.citation: J Physiol. 2008 Sep 15;586(18):4371-6
references.pmid: 18617561
references.citation: Mol Genet Metab. 2001 Nov;74(3):293-302
references.pmid: 11708858
references.citation: Invest Ophthalmol Vis Sci. 2005 Jan;46(1):137-42
references.pmid: 15623766
references.citation: J Neurosci Methods. 2010 Jan 30;186(1):29-34
references.pmid: 19900474
references.citation: Curr Biol. 2010 Feb 23;20(4):381-6
references.pmid: 20153194
references.citation: Invest Ophthalmol Vis Sci. 1987 Dec;28(12):1888-904
references.pmid: 3316105
references.citation: Curr Opin Neurobiol. 2001 Aug;11(4):475-80
references.pmid: 11502395
references.citation: J Neurol Neurosurg Psychiatry. 1951 Aug;14(3):216-21
references.pmid: 14874135
references.citation: PLoS One. 2008 Jul 23;3(7):e2748
references.pmid: 18648503
references.citation: J Biol Chem. 1994 Jul 8;269(27):17954-9
references.pmid: 8027053
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14512-7
references.pmid: 9405644
references.citation: J Neurophysiol. 2005 Jan;93(1):84-93
references.pmid: 15229213
references.citation: Dis Model Mech. 2010 May-Jun;3(5-6):343-53
references.pmid: 20335444
references.citation: Neuron. 2001 Jun;30(3):771-80
references.pmid: 11430810
references.citation: Science. 1999 Mar 5;283(5407):1482-8
references.pmid: 10066162
references.citation: Trends Cardiovasc Med. 2009 Feb;19(2):38-43
references.pmid: 19577710
references.citation: Exp Eye Res. 2009 Mar;88(3):553-60
references.pmid: 19084520
references.citation: J Neurophysiol. 1996 Dec;76(6):3842-9
references.pmid: 8985882
references.citation: J Neurosci. 1992 Mar;12(3):840-53
references.pmid: 1312136
references.citation: Prog Retin Eye Res. 1998 Jul;17(3):429-42
references.pmid: 9695799
references.citation: Vision Res. 1998 May;38(10):1335-9
references.pmid: 9667001
references.citation: J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S339-43
references.pmid: 19924563
references.citation: J Neurosci Methods. 2004 May 30;135(1-2):205-10
references.pmid: 15020104
references.citation: Trends Neurosci. 2005 Aug;28(8):395-6
references.pmid: 15979167
references.citation: Zebrafish. 2004;1(2):121-31
references.pmid: 18248224
references.citation: J Neurosci. 1995 Jul;15(7 Pt 2):5179-91
references.pmid: 7623144
references.citation: Curr Biol. 2008 Dec 23;18(24):1917-21
references.pmid: 19084410
references.citation: Curr Opin Neurobiol. 2002 Aug;12(4):405-10
references.pmid: 12139988
references.citation: Dev Biol. 2005 Sep 1;285(1):138-55
references.pmid: 16231865
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4584-9
references.pmid: 15070761
references.citation: Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10545-9
references.pmid: 7479837
references.citation: Nature. 2005 Dec 15;438(7070):960-6
references.pmid: 16355161
references.citation: Invest Ophthalmol Vis Sci. 2000 Feb;41(2):337-48
references.pmid: 10670460
references.citation: J Neurophysiol. 2005 Jan;93(1):94-107
references.pmid: 15229214
references.citation: J Neurosci. 1999 Oct 1;19(19):8603-15
references.pmid: 10493760
references.citation: Development. 1996 Dec;123:1-36
references.pmid: 9007226
references.citation: Development. 1996 Dec;123:369-89
references.pmid: 9007256
references.citation: J Physiol. 2009 Sep 15;587(Pt 18):4481-95
references.pmid: 19651763
references.citation: J Neurophysiol. 2008 Oct;100(4):1995-2004
references.pmid: 18684905